CFO
DVAX

Callan Family Office’s Dynavax Technologies DVAX Stock Holding History

Callan Family Office’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,766
Closed -$107K – 881
2025
Q2 		$107K Buy
+10,766
New +$113K ﹤0.01% 893

Other funds holding DVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Callan Family Office's DVAX Position: Q3 2025 in Review

Callan Family Office sold out of Dynavax Technologies (DVAX) in Q3 2025, closing a stake of 10,766 shares — an estimated $107K sold.

Callan Family Office first reported a position in DVAX in Q2 2025 and held it in 1 quarter. The position peaked at $107K in Q2 2025. 270 funds tracked by Wall St. Rank hold DVAX as of Q3 2025.

  • Callan Family Office reported no remaining Dynavax Technologies position as of Q3 2025 after selling out during the quarter.
  • Callan Family Office sold 10,766 Dynavax Technologies shares in Q3 2025, an estimated $107K.
  • Callan Family Office first reported a position in Dynavax Technologies in Q2 2025 and held it in 1 quarter.
  • Callan Family Office's Dynavax Technologies position peaked at $107K in Q2 2025.
  • 270 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2025.

Based on Callan Family Office's 13F filing for Q3 2025, filed 4 Nov 2025.